Fully human recombinant antibodies against EphA2 from a multi-tumor patient immune library suitable for tumor-targeted therapy
Author:
Affiliation:
1. Public Center of Experimental Technology, the School of Basic Medical Science, Southwest Medical University, Luzhou, China
2. Department of Laboratory Medicine, The Affiliated Hospital of Southwest Medical University, Sichuan, P.R. China
Funder
Luzhou Municipal Government
The joint project of the Luzhou Municipal Government and Southwest Medical University
The joint project of People’s Government of Luxian County and Southwest Medical University
Joint Project of Sichuan University and Luzhou Industrial Research Institute
Publisher
Informa UK Limited
Subject
Applied Microbiology and Biotechnology,General Medicine,Bioengineering,Biotechnology
Link
https://www.tandfonline.com/doi/pdf/10.1080/21655979.2021.1996807
Reference80 articles.
1. Targeting EphA2 in cancer
2. Emerging strategies for EphA2 receptor targeting for cancer therapeutics
3. Roles of EphA2 in Development and Disease
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Ephrin receptor type-A2 (EphA2) targeting in cancer: a patent review (2018–present);Expert Opinion on Therapeutic Patents;2024-09-11
2. Advancements in ovarian cancer immunodiagnostics and therapeutics via phage display technology;Frontiers in Immunology;2024-05-28
3. Fully human anti-B7-H3 recombinant antibodies inhibited tumor growth by increasing T cell infiltration;International Immunopharmacology;2024-05
4. Construction of a Human Immune Library from Gallbladder Cancer Patients for the Single-Chain Fragment Variable (scFv) Antibody Selection against Claudin 18.2 via Phage Display;Antibodies;2024-03-12
5. Combination of protein and cell internalization SELEX identifies a potential RNA therapeutic and delivery platform to treat EphA2-expressing tumors;Molecular Therapy - Nucleic Acids;2023-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3